FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912156356> ?p ?o ?g. }

• W2912156356 abstract "Background Beyond their potent LDL (low‐density lipoprotein) cholesterol ( LDL ‐C)–lowering efficacy (50–60%), PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors also reduce Lp(a) (lipoprotein[a]) levels by 25% to 30%, suggesting a 2:1 response ratio. We aimed to characterize the relationship between LDL ‐C and Lp(a) lowering by evolocumab, a PCSK 9 inhibitor, in a large clinical trial population and to determine the prevalence of concordant/discordant LDL ‐C and Lp(a) responses to PCSK 9 inhibition. Methods and Results Data were analyzed from 4 randomized, 12‐week, multicenter, phase 3 evolocumab trials. Patients with familial hypercholesterolemia, nonfamilial hypercholesterolemia, or statin intolerance participated in the trials. The main measure was the degree of concordance or discordance of LDL ‐C and Lp(a) in response to PCSK 9 inhibition; concordant response was defined as LDL ‐C reduction >35% and Lp(a) reduction >10%. The study cohort comprised 895 patients (438 female; median age: 59.0 years [interquartile range: 51–66 years]). Baseline mean level of LDL ‐C was 133.6 mg/dL (SE: 1.7) and median Lp(a) level was 46.4 mg/dL (interquartile range: 18.4–82.4 mg/dL). A discordant response was observed in 165 (19.7%) patients. With these cutoffs, the prevalence of discordance was higher when considering baseline Lp(a) concentrations >30 mg/dL (26.5%) or >50 mg/dL (28.6%). Conclusions We demonstrate high prevalence of discordance in LDL ‐C and Lp(a) reduction in response to evolocumab, particularly when considering higher baseline Lp(a) concentrations, indicating the possibility of alternative pathways beyond LDLR ( LDL receptor)–mediated clearance involved in Lp(a) reduction by evolocumab. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique identifiers: NCT 01763827, NCT 01763866, NCT 01763905, NCT 01763918." @default.
• W2912156356 created "2019-02-21" @default.
• W2912156356 creator A5021718742 @default.
• W2912156356 creator A5022083191 @default.
• W2912156356 creator A5034399298 @default.
• W2912156356 creator A5064025137 @default.
• W2912156356 creator A5067245152 @default.
• W2912156356 creator A5067797353 @default.
• W2912156356 creator A5068826784 @default.
• W2912156356 date "2019-02-19" @default.
• W2912156356 modified "2023-10-17" @default.
• W2912156356 title "Relationship Between Low‐Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab" @default.
• W2912156356 cites W121888607 @default.
• W2912156356 cites W161816689 @default.
• W2912156356 cites W1990204315 @default.
• W2912156356 cites W2009191878 @default.
• W2912156356 cites W2019295985 @default.
• W2912156356 cites W2024930123 @default.
• W2912156356 cites W2041093009 @default.
• W2912156356 cites W2081856635 @default.
• W2912156356 cites W2083516336 @default.
• W2912156356 cites W2098230963 @default.
• W2912156356 cites W2098890974 @default.
• W2912156356 cites W2099136586 @default.
• W2912156356 cites W2121581403 @default.
• W2912156356 cites W2149949008 @default.
• W2912156356 cites W2163238468 @default.
• W2912156356 cites W2184549447 @default.
• W2912156356 cites W2284076444 @default.
• W2912156356 cites W2415117000 @default.
• W2912156356 cites W2521514852 @default.
• W2912156356 cites W2526246517 @default.
• W2912156356 cites W2543585581 @default.
• W2912156356 cites W2552067282 @default.
• W2912156356 cites W2570683458 @default.
• W2912156356 cites W2586892149 @default.
• W2912156356 cites W2590841352 @default.
• W2912156356 cites W2592174078 @default.
• W2912156356 cites W2596179513 @default.
• W2912156356 cites W2789891083 @default.
• W2912156356 cites W2883271040 @default.
• W2912156356 cites W2899997727 @default.
• W2912156356 cites W81463456 @default.
• W2912156356 cites W98619866 @default.
• W2912156356 doi "https://doi.org/10.1161/jaha.118.010932" @default.
• W2912156356 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6405654" @default.
• W2912156356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30755061" @default.
• W2912156356 hasPublicationYear "2019" @default.
• W2912156356 type Work @default.
• W2912156356 sameAs 2912156356 @default.
• W2912156356 citedByCount "44" @default.
• W2912156356 countsByYear W29121563562019 @default.
• W2912156356 countsByYear W29121563562020 @default.
• W2912156356 countsByYear W29121563562021 @default.
• W2912156356 countsByYear W29121563562022 @default.
• W2912156356 countsByYear W29121563562023 @default.
• W2912156356 crossrefType "journal-article" @default.
• W2912156356 hasAuthorship W2912156356A5021718742 @default.
• W2912156356 hasAuthorship W2912156356A5022083191 @default.
• W2912156356 hasAuthorship W2912156356A5034399298 @default.
• W2912156356 hasAuthorship W2912156356A5064025137 @default.
• W2912156356 hasAuthorship W2912156356A5067245152 @default.
• W2912156356 hasAuthorship W2912156356A5067797353 @default.
• W2912156356 hasAuthorship W2912156356A5068826784 @default.
• W2912156356 hasBestOaLocation W29121563561 @default.
• W2912156356 hasConcept C119060515 @default.
• W2912156356 hasConcept C126322002 @default.
• W2912156356 hasConcept C134018914 @default.
• W2912156356 hasConcept C2776104379 @default.
• W2912156356 hasConcept C2776839432 @default.
• W2912156356 hasConcept C2778114629 @default.
• W2912156356 hasConcept C2778163477 @default.
• W2912156356 hasConcept C2778715236 @default.
• W2912156356 hasConcept C2778849439 @default.
• W2912156356 hasConcept C2780072125 @default.
• W2912156356 hasConcept C2780745583 @default.
• W2912156356 hasConcept C2780902209 @default.
• W2912156356 hasConcept C2780948078 @default.
• W2912156356 hasConcept C2908647359 @default.
• W2912156356 hasConcept C43554185 @default.
• W2912156356 hasConcept C71924100 @default.
• W2912156356 hasConcept C90924648 @default.
• W2912156356 hasConcept C99454951 @default.
• W2912156356 hasConceptScore W2912156356C119060515 @default.
• W2912156356 hasConceptScore W2912156356C126322002 @default.
• W2912156356 hasConceptScore W2912156356C134018914 @default.
• W2912156356 hasConceptScore W2912156356C2776104379 @default.
• W2912156356 hasConceptScore W2912156356C2776839432 @default.
• W2912156356 hasConceptScore W2912156356C2778114629 @default.
• W2912156356 hasConceptScore W2912156356C2778163477 @default.
• W2912156356 hasConceptScore W2912156356C2778715236 @default.
• W2912156356 hasConceptScore W2912156356C2778849439 @default.
• W2912156356 hasConceptScore W2912156356C2780072125 @default.
• W2912156356 hasConceptScore W2912156356C2780745583 @default.
• W2912156356 hasConceptScore W2912156356C2780902209 @default.
• W2912156356 hasConceptScore W2912156356C2780948078 @default.
• W2912156356 hasConceptScore W2912156356C2908647359 @default.
• W2912156356 hasConceptScore W2912156356C43554185 @default.
• W2912156356 hasConceptScore W2912156356C71924100 @default.
• W2912156356 hasConceptScore W2912156356C90924648 @default.

• next